Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis

Abstract: High-grade B-cell lymphomas (HGBL, including double-hit/triple-hit [HGBL-DH/TH], and HGBL not otherwise specified) have a poor prognosis upon failure of first-line therapy. Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for third-line aggressive large B-cell lymphomas (LBCL) resu...

Полное описание

Библиографические подробности

Главные авторы:	Anna Dodero, Giusy Ceparano, Beatrice Casadei, Piera Angelillo, Stefania Bramanti, Maria Chiara Tisi, Silva Ljevar, Federico Stella, Annalisa Chiappella, Barbara Botto, Ilaria Cutini, Giada Zanirato, Patrizia Chiusolo, Anna Maria Barbui, Mirko Farina, Alice Di Rocco, Giovanni Grillo, Jacopo Olivieri, Mauro Krampera, Marco Ladetto, Anna Guidetti, Pier Luigi Zinzani, Cristiana Carniti, Paolo Corradini
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2025-12-01
Серии:	Blood Advances
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2473952925004690
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!